NYSE · STEHealthcareOrthopedic & Surgical Supplies

STERIS plc (STE)

$247.91+7.16%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$231.35▼ 2.52% in range
Nov 3, 2025Low $199.40 · High $268.65Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

STERIS closed at $247.91 on Nov 4, up 7.16%, 7.7% below its 52-week closing high. Volume of 1.4M shares was 1.98× its 20-day average (above normal).

Split-adjusted performance: +18.8% over one month, +15.6% over six months, +4.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.49B, up 7.3% from a year earlier, with a net margin of 13.4%.

Short interest was 2.4M shares at the Oct 15 settlement, down 16.1% from the prior report (2.5% of float, 3.6 days to cover).

Market cap$24.17B97.5M shares
Revenue · quarter$1.49B+7.3% YoY
Diluted EPS$2.04+14.0% YoY
P/E · TTM30.0×P/S 4.0×
Net margin13.4%Gross 45.8%
Dividend yield1.11%$0.69 last paid
52-week range199.40 – 268.65−7.7% from high
Volume1.4M1.98× 20-day avg
Volatility · 60d25.5%Annualised
Short % of float2.5%3.6 days to cover
Net cash-$1.41BCash $482.3M
Next earnings—Not scheduled
Split-adjusted performance
1W +8.4%1M +18.8%3M +7.0%6M +15.6%YTD −2.2%1Y +4.5%3Y +18.6%5Y +6.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum70
Revenue growth37
Net margin90
Value (low P/E)43
Size91

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →
Shares short2.4M−16.1% vs prior
Days to cover3.6Settled Oct 15
% of float2.5%
Short vol. 10d55.1%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
STESTERIS$247.91+7.16%+15.6%+7.3%13.4%30.0$24.17B
ZBHZimmer Biomet Holdings$110.15+13.49%+33.0%+4.8%9.1%26.0$21.01BCompare
ALGNAlign Technology$164.90+8.79%−5.2%+4.3%10.3%28.3$11.71BCompare
EWEdwards Lifesciences$99.37+4.39%+19.4%+13.6%13.9%57.0$57.28BCompare
MSAMine Safety Incorporated$177.60+2.03%+2.1%+14.5%10.9%22.6$6.85BCompare
ISRGIntuitive Surgical$482.10+9.38%+6.7%+21.7%17.1%57.6$170.32BCompare
ESTAEstablishment Labs Holdings$66.94+9.02%−10.2%+31.7%−17.4%—$1.99BCompare
ENOVEnovis$24.42+16.90%−1.7%+3.2%−0.2%—$1.41BCompare
CDRECadre Holdings$30.84−0.71%0.0%+31.8%5.5%36.6$1.32BCompare

Quick answers

What does STERIS do?
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world.
What is STE's market cap?
$24.17B, based on the Nov 4 close of $247.91.
What is STE's P/E ratio?
30.0× trailing-twelve-month earnings of $805.10M.
Does STERIS pay a dividend?
Yes. The latest regular dividend was $0.69 per share (ex-date Sep 4), an annualised yield of 1.11%.
How much of STE is sold short?
2.4M shares, 2.5% of float, as of Oct 15, 2026.
What sector is STE in?
Healthcare, in the Orthopedic & Surgical Supplies industry.

About STERIS

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

HQ: Dublin, L217,937 employeesListed Jun 2, 1992steris.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology